Narrow search
Showing 1 - 8 of 8
Cover Image
Presenting Germany's drug pricing rule as a cost-per-QALY rule
Gandjour, Afschin - In: Health care management science 15 (2012) 2, pp. 103-107
Persistent link: https://www.econbiz.de/10009551689
Cover Image
Comment on "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany"
Gandjour, Afschin - In: The European journal of health economics : HEPAC ; … 19 (2018) 3, pp. 471-472
Persistent link: https://www.econbiz.de/10011952176
Cover Image
Patient preferences : a Trojan horse for evidence-based medicine?
Gandjour, Afschin - In: The European journal of health economics : HEPAC ; … 19 (2018) 1, pp. 167-172
Persistent link: https://www.econbiz.de/10011946179
Cover Image
Value-based pricing of a COVID-19 vaccine
Gandjour, Afschin - In: The quarterly review of economics and finance : journal … 84 (2022), pp. 1-8
Persistent link: https://www.econbiz.de/10013334619
Cover Image
Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany : a comment
Gandjour, Afschin - In: The European journal of health economics 24 (2023) 7, pp. 1243-1244
Persistent link: https://www.econbiz.de/10014328184
Cover Image
Pharmaceutical spending and early-stage innovation in EU countries
Kourouklis, Dimitrios; Gandjour, Afschin - In: Industry and innovation 29 (2022) 10, pp. 1141-1170
Persistent link: https://www.econbiz.de/10013493053
Cover Image
Authors' reply to Gandjour: "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany"
Kuhlmann, Alexander; Schulenburg, Johann-Matthias von der - In: The European journal of health economics : HEPAC ; … 19 (2018) 3, pp. 473-481
Persistent link: https://www.econbiz.de/10011952179
Cover Image
Predictors of negotiated prices for new drugs in Germany
Gandjour, Afschin; Schüßler, Sofia; Hammerschmidt, Thomas - In: The European journal of health economics : HEPAC ; … 21 (2020) 7, pp. 1049-1057
Persistent link: https://www.econbiz.de/10012489955